Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
I consider myself privileged to be part of the team.
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
Everyone pulling together when the pressure mounts.
O que faz você mais feliz no trabalho?
Seeing new effective drugs coming to market.
Quais são algumas das melhores coisas da sua equipe?
They are all highly competent people driven by doing good.
O que você mais gosta nos lideres?
KPTI is a company that is always striving to get better.
Other Employee Reviews for Karyopharm Therapeutics
×